Search

everythinglearnresearchcommunity

for

Search:↓

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

New, cheaper method measures finasteride in tablets accurately and quickly.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.

Certain drugs change freshwater snail shells to a "banana" shape.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride modifies 5-alpha-reductases through a two-step process, affecting inhibitor potency and possibly causing side effects.

SIPHL1 from tomato enhances plants' response to low phosphate levels.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Compound 15a was effective in inhibiting 5α-reductase.

Injecting CHIR-99021 into goose embryos improves feather growth by changing gene activity and energy processes.

Plant extracts may help treat hormone-related hair loss.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Androgens, like DHT, affect hair growth and treatments like finasteride may help.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.